These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 18306146

  • 1. Overcoming the heat-sink phenomenon: successful radiofrequency thermal ablation of liver tumors in contact with blood vessels.
    Thanos L, Mylona S, Galani P, Pomoni M, Pomoni A, Koskinas I.
    Diagn Interv Radiol; 2008 Mar; 14(1):51-6. PubMed ID: 18306146
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
    Kim YS, Lee WJ, Rhim H, Lim HK, Choi D, Lee JY.
    AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
    [Abstract] [Full Text] [Related]

  • 4. Computed tomography-guided radiofrequency ablation of hepatocellular carcinoma: treatment efficacy and complications.
    Laspas F, Sotiropoulou E, Mylona S, Manataki A, Tsagouli P, Tsangaridou I, Thanos L.
    J Gastrointestin Liver Dis; 2009 Sep; 18(3):323-8. PubMed ID: 19795027
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of CT-guided percutaneous thermal ablation for hepatocellular carcinoma adjacent to the second porta hepatis.
    Xie L, Cao F, Qi H, Song Z, Shen L, Chen S, Hu Y, Chen C, Fan W.
    Int J Hyperthermia; 2019 Sep; 36(1):1122-1128. PubMed ID: 31739695
    [Abstract] [Full Text] [Related]

  • 6. Percutaneous radiofrequency ablation of malignant liver tumors with ultrasound and CT fusion imaging guidance.
    Xu ZF, Xie XY, Kuang M, Liu GJ, Chen LD, Zheng YL, Lu MD.
    J Clin Ultrasound; 2014 Sep; 42(6):321-30. PubMed ID: 24615771
    [Abstract] [Full Text] [Related]

  • 7. Complete radio frequency ablation of hepatocellular carcinoma adjacent to the main bile duct and blood vessels between the first and the second hepatic portal.
    Kai J, Ming S, Yang L, Wen-zhi Z, Xiang-qian Z, Zhe L, Wen-ping L, Zhi-wei L, Jia-hong D.
    Cell Biochem Biophys; 2013 Jun; 66(2):397-402. PubMed ID: 23179404
    [Abstract] [Full Text] [Related]

  • 8. Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approach.
    Kim HO, Kim SK, Son BH, Yoo CH, Hong HP, Cho YK, Kim BI.
    Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):591-6. PubMed ID: 20007075
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Percutaneous microwave ablation for hepatocellular carcinoma adjacent to large vessels: a long-term follow-up.
    Huang S, Yu J, Liang P, Yu X, Cheng Z, Han Z, Li Q.
    Eur J Radiol; 2014 Mar; 83(3):552-8. PubMed ID: 24418287
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Percutaneous radiofrequency ablation of liver tumors using the LeVeen 4 cm array probe].
    Pitton MB, Herber S, Raab P, Mönch C, Wunsch M, Schneider J, Schweden F, Otto G, Thelen M.
    Rofo; 2003 Nov; 175(11):1525-31. PubMed ID: 14610704
    [Abstract] [Full Text] [Related]

  • 13. Subcapsular liver tumors treated with percutaneous radiofrequency ablation: a prospective comparison with nonsubcapsular liver tumors for safety and effectiveness.
    Sartori S, Tombesi P, Macario F, Nielsen I, Tassinari D, Catellani M, Abbasciano V.
    Radiology; 2008 Aug; 248(2):670-9. PubMed ID: 18519740
    [Abstract] [Full Text] [Related]

  • 14. [Efficacy of radiofrequency ablation of 343 patients with hepatic tumor and the relevant complications].
    Chen MH, Yan K, Yang W, Gao W, Dai Y, Wang YB, Zhang H, Huo L, Xing BC, Huang XF.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun 18; 37(3):292-6. PubMed ID: 15968323
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Radiofrequency ablation of unresectable hepatic tumors.
    Geyik S, Akhan O, Abbasoğlu O, Akinci D, Ozkan OS, Hamaloğlu E, Ozmen M.
    Diagn Interv Radiol; 2006 Dec 18; 12(4):195-200. PubMed ID: 17160805
    [Abstract] [Full Text] [Related]

  • 17. [Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy].
    Yang W, Chen MH, Yan K, Gao W, Yin SS, Wang YB, Zhang XP, Xing BC, Huang XF.
    Zhonghua Wai Ke Za Zhi; 2005 Aug 01; 43(15):980-4. PubMed ID: 16194353
    [Abstract] [Full Text] [Related]

  • 18. Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins.
    Distelmaier M, Barabasch A, Heil P, Kraemer NA, Isfort P, Keil S, Kuhl CK, Bruners P.
    Radiology; 2017 Dec 01; 285(3):1023-1031. PubMed ID: 28799842
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?
    Zavaglia C, Corso R, Rampoldi A, Vinci M, Belli LS, Vangeli M, Solcia M, Castoldi C, Prisco C, Vanzulli A, Pinzello G.
    Eur J Gastroenterol Hepatol; 2008 Mar 01; 20(3):196-201. PubMed ID: 18301300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.